美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Elicio Therapeutics

5.07

-0.1500-2.87%

盤後：5.070.00000.00%16:00 EDT

成交量：11.65萬

成交額：61.69萬

市值：8,081.11萬

市盈率：-1.19

高：5.60

開：5.25

低：5.00

收：5.22

資料載入中...

總覽公司新聞公告

Elicio Therapeutics, Inc.盤中異動急速上漲5.50%

Elicio Therapeutics, Inc.盤中異動早盤快速下挫6.94%

Elicio Therapeutics, Inc.盤中異動股價大漲7.85%報5.73美元

Elicio Therapeutics, Inc.盤中異動大幅跳水6.91%報5.60美元

Elicio Therapeutics, Inc.盤中異動急速拉昇9.28%報5.65美元

Elicio Therapeutics, Inc.2024財年實現淨利潤-51.90百萬美元，同比減少47.44%

嗡嗡聲--美國股票走勢-Veritex、博彩與休閒產業、蘋果公司

嗡嗡聲--美國股票走勢-Veritex、博彩與休閒產業、蘋果公司

BUZZ-Elicio 公司推遲中期癌症疫苗研究；股價暴跌

Elicio Therapeutics Inc 預計每股虧損 87 美分 - 財報前瞻

Elicio Therapeutics, Inc.盤中異動快速下挫6.02%報7.81美元

Elicio Therapeutics, Inc.盤中異動早盤大幅拉昇5.68%

Elicio Therapeutics, Inc.盤中異動急速上漲7.89%

Elicio Therapeutics, Inc.盤中異動早盤股價大跌5.21%

Elicio Therapeutics, Inc.盤中異動股價大漲6.79%報8.65美元

Elicio Therapeutics, Inc.盤中異動大幅拉昇5.33%

Elicio Therapeutics, Inc.盤中異動早盤股價大漲6.58%

Elicio Therapeutics, Inc.盤中異動急速下挫7.09%報8.65美元

Elicio Therapeutics, Inc.盤中異動早盤快速下跌5.63%報8.89美元

Elicio Therapeutics, Inc.盤中異動股價大跌15.98%報8.10美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ELTX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","market":"US","secType":"STK","nameCN":"Elicio Therapeutics","latestPrice":5.07,"timestamp":1745524800000,"preClose":5.22,"halted":0,"volume":116463,"hourTrading":{"tag":"盘后","latestPrice":5.07,"preClose":5.07,"latestTime":"16:00 EDT","volume":227,"amount":1150.89,"timestamp":1745524802052},"delay":0,"floatShares":10249455,"shares":15939069,"eps":-4.25289,"marketStatus":"未開盤","change":-0.15,"latestTime":"04-24 16:00:00 EDT","open":5.25,"high":5.6,"low":5,"amount":616892.822,"amplitude":0.114943,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.25289,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745568000000},"marketStatusCode":0,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":5.22,"postHourTrading":{"tag":"盘后","latestPrice":5.07,"preClose":5.07,"latestTime":"16:00 EDT","volume":227,"amount":1150.89,"timestamp":1745524802052},"volumeRatio":3.268917,"impliedVol":0.515,"impliedVolPercentile":0.3333},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","floatShares":10249455,"roa":"-101.64%","roe":"-170157.38%","lyrEps":-4.25289,"volumeRatio":3.268917,"shares":15939069,"dividePrice":0,"high":5.6,"amplitude":0.114943,"preClose":5.22,"low":5,"week52Low":3.3419,"pbRate":"-7.14","week52High":11.45,"institutionHeld":0,"latestPrice":5.07,"eps":-4.25289,"divideRate":0,"volume":116463,"delay":0,"ttmEps":-4.25289,"open":5.25,"prevYearClose":5.1,"prevWeekClose":4.76,"prevMonthClose":6.16,"prevQuarterClose":6.16,"fiveDayClose":4.86,"twentyDayClose":8,"sixtyDayClose":8.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529582035","title":"Elicio Therapeutics, Inc.盤中異動 急速上漲5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529582035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529582035?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 22:06","pubTimestamp":1745330766,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时06分，Elicio Therapeutics, Inc.股票出现异动，股价快速拉升5.50%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422220606a6c3e2fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422220606a6c3e2fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","ELTX","LENZ"],"gpt_icon":0},{"id":"2526839992","title":"Elicio Therapeutics, Inc.盤中異動 早盤快速下挫6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526839992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526839992?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 23:10","pubTimestamp":1744211407,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日23时10分，Elicio Therapeutics, Inc.股票出现波动，股价大幅跳水6.94%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.51%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409231007a6b59340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409231007a6b59340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2525818174","title":"Elicio Therapeutics, Inc.盤中異動 股價大漲7.85%報5.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525818174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525818174?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 21:34","pubTimestamp":1744119267,"startTime":"0","endTime":"0","summary":"北京时间2025年04月08日21时34分，Elicio Therapeutics, Inc.股票出现异动，股价大幅拉升7.85%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.67%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213427a6b42c3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213427a6b42c3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ELTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2525028328","title":"Elicio Therapeutics, Inc.盤中異動 大幅跳水6.91%報5.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525028328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525028328?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 21:52","pubTimestamp":1744033924,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时52分，Elicio Therapeutics, Inc.股票出现波动，股价大幅跳水6.91%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.79%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407215204a451026d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407215204a451026d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2524281266","title":"Elicio Therapeutics, Inc.盤中異動 急速拉昇9.28%報5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524281266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524281266?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 21:34","pubTimestamp":1743687266,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日21时34分，Elicio Therapeutics, Inc.股票出现波动，股价大幅拉升9.28%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213426a44cbb84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213426a44cbb84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2524419564","title":"Elicio Therapeutics, Inc.2024財年實現淨利潤-51.90百萬美元，同比減少47.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524419564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524419564?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 18:00","pubTimestamp":1743501622,"startTime":"0","endTime":"0","summary":"4月1日，Elicio Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-51.90百万美元，同比减少47.44%；其中营业收入为0.00美元，每股基本收益为-4.25美元。机构评级：截至2025年4月1日，当前有1家机构对Elicio Therapeutics, Inc.目标价做出预测，其中目标均价为12.00美元，其中最低目标价为12.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401180027a6abbe1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401180027a6abbe1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ELTX"],"gpt_icon":0},{"id":"2524975071","title":"嗡嗡聲--美國股票走勢-Veritex、博彩與休閒產業、蘋果公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2524975071","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524975071?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 02:32","pubTimestamp":1743445923,"startTime":"0","endTime":"0","summary":"嗡嗡声--美国股票走势-Veritex、博彩与休闲产业、苹果公司路透社3月31日 - 在特朗普政府即将宣布关税计划之前，投资者对美国股市持谨慎态度，标普500指数和纳斯达克指数周一下跌，科技股跌幅最大。.N 美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.21%，报41,669.35点。标准普尔500指数.SPX下跌0.43%，报5556.97点；纳斯达克综合指数.IXIC下跌1.24%，报17107.39点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3S3QE172:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1400636574.HKD","BK4568","ELTX","COOP","PG","FBK","FLG","SRPT","TSYW.SI","LU1989764664.SGD","HMST","LYV","PINS","IDYA","EBS","LU2213496289.HKD","TSHA","GSK.UK","AIG","BLUE","IE00BJT1NW94.SGD","LU2290526834.HKD","LPLA","IIPR","GT","PL","NOVA","NEM","GLPI","ENZ","VBTX","NVAX","LITB","ALNY","ALSN","LU2108987350.USD","RKT","LU2244417387.USD","BK4605","SSBK","LU0289739699.SGD","BK4566","GATE","LU0124676726.USD","SLDB"],"gpt_icon":1},{"id":"2524074975","title":"嗡嗡聲--美國股票走勢-Veritex、博彩與休閒產業、蘋果公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2524074975","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524074975?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 02:32","pubTimestamp":1743445923,"startTime":"0","endTime":"0","summary":"嗡嗡声--美国股票走势-Veritex、博彩与休闲产业、苹果公司路透社3月31日 - 在特朗普政府即将宣布关税计划之前，投资者对美国股市持谨慎态度，标普500指数和纳斯达克指数周一下跌，科技股跌幅最大。.N 美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.21%，报41,669.35点。标准普尔500指数.SPX下跌0.43%，报5556.97点；纳斯达克综合指数.IXIC下跌1.24%，报17107.39点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3T3QE172:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENZ","HMST","GT","FLG","BK4568","LU2244417387.USD","NOVA","BLUE","LU1989764664.SGD","BK4566","PG","GATE","TSYW.SI","ALSN","GLPI","NVAX","PINS","LU2108987350.USD","IIPR","ELTX","AIG","FBK","COOP","LU2290526834.HKD","NEM","LYV","IDYA","EBS","RKT","SLDB","LU0124676726.USD","SSBK","LU1400636574.HKD","LPLA","GSK.UK","VBTX","LITB","LU0289739699.SGD","SRPT","TSHA","BK4605","ALNY","LU2213496289.HKD","PL","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2524397896","title":"BUZZ-Elicio 公司推遲中期癌症疫苗研究；股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2524397896","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524397896?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 01:26","pubTimestamp":1743441961,"startTime":"0","endTime":"0","summary":"BUZZ-Elicio 公司推迟中期癌症疫苗研究；股价暴跌3月31日 - ** 生物技术公司Elicio Therapeutics的ELTX.O股价下跌14%，跌至6.71美元的两个多月低点。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3S3QE15I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELTX","BK4007"],"gpt_icon":0},{"id":"2522207816","title":"Elicio Therapeutics Inc  預計每股虧損 87 美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2522207816","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522207816?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 20:32","pubTimestamp":1742905974,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics Inc  预计每股亏损 87 美分 - 财报前瞻Elicio Therapeutics Inc ELTX.OQ ELTX.O预计在3月27日公布截至2024年12月31日的业绩时，季度营收将没有变化(预计)。LSEG 的分析师平均预计 Elicio Therapeutics Inc 每股亏损 87 美分。华尔街对 Elicio Therapeutics Inc 的 12 个月目标价中位数为 11.00 美元，高于其上次收盘价 8.50 美元。3月25日 - 以前季度业绩。除非另有说明，所有数字均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL3S3Q80TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX"],"gpt_icon":0},{"id":"2516065459","title":"Elicio Therapeutics, Inc.盤中異動 快速下挫6.02%報7.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516065459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516065459?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 02:08","pubTimestamp":1741025317,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时08分，Elicio Therapeutics, Inc.股票出现异动，股价大幅跳水6.02%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304020837abe6733b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304020837abe6733b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ELTX","BK4139"],"gpt_icon":0},{"id":"2516379751","title":"Elicio Therapeutics, Inc.盤中異動 早盤大幅拉昇5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516379751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516379751?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 23:10","pubTimestamp":1740755402,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时10分，Elicio Therapeutics, Inc.股票出现异动，股价快速上涨5.68%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231002a2580afc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231002a2580afc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ELTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2514018228","title":"Elicio Therapeutics, Inc.盤中異動 急速上漲7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514018228?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 22:57","pubTimestamp":1740495451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时57分，Elicio Therapeutics, Inc.股票出现波动，股价大幅上涨7.89%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225731abdc8476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225731abdc8476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","ELTX","LENZ"],"gpt_icon":0},{"id":"2513477855","title":"Elicio Therapeutics, Inc.盤中異動 早盤股價大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513477855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513477855?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 23:15","pubTimestamp":1740410110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时15分，Elicio Therapeutics, Inc.股票出现异动，股价急速下跌5.21%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022423151198910089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022423151198910089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","ELTX","BK4139"],"gpt_icon":0},{"id":"2513629117","title":"Elicio Therapeutics, Inc.盤中異動 股價大漲6.79%報8.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513629117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513629117?lang=zh_tw&edition=fundamental","pubTime":"2025-02-21 23:09","pubTimestamp":1740150582,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时09分，Elicio Therapeutics, Inc.股票出现异动，股价快速拉升6.79%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230942988de732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230942988de732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ELTX"],"gpt_icon":0},{"id":"2511461563","title":"Elicio Therapeutics, Inc.盤中異動 大幅拉昇5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511461563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511461563?lang=zh_tw&edition=fundamental","pubTime":"2025-02-15 02:14","pubTimestamp":1739556867,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日02时14分，Elicio Therapeutics, Inc.股票出现波动，股价大幅上涨5.33%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021502142896234e44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021502142896234e44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ELTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2510286325","title":"Elicio Therapeutics, Inc.盤中異動 早盤股價大漲6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510286325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510286325?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 22:31","pubTimestamp":1739197902,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Elicio Therapeutics, Inc.股票出现波动，股价快速拉升6.58%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223142a240a1e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223142a240a1e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELTX","BK4007","LENZ"],"gpt_icon":0},{"id":"2508869142","title":"Elicio Therapeutics, Inc.盤中異動 急速下挫7.09%報8.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508869142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508869142?lang=zh_tw&edition=fundamental","pubTime":"2025-02-03 23:12","pubTimestamp":1738595549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时12分，Elicio Therapeutics, Inc.股票出现波动，股价急速跳水7.09%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231229987975c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231229987975c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2507034965","title":"Elicio Therapeutics, Inc.盤中異動 早盤快速下跌5.63%報8.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507034965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507034965?lang=zh_tw&edition=fundamental","pubTime":"2025-01-31 22:38","pubTimestamp":1738334306,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时38分，Elicio Therapeutics, Inc.股票出现波动，股价大幅下跌5.63%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223826a23543af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223826a23543af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2507353621","title":"Elicio Therapeutics, Inc.盤中異動 股價大跌15.98%報8.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507353621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507353621?lang=zh_tw&edition=fundamental","pubTime":"2025-01-30 22:32","pubTimestamp":1738247527,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时32分，Elicio Therapeutics, Inc.股票出现异动，股价急速跳水15.98%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223207a2345521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223207a2345521&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ELTX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"ELTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.94,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-1.02},{"market":"US","date":"2024-11-13","symbol":"ELTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.81,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2024-08-13","symbol":"ELTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.96,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2024-05-15","symbol":"ELTX","fiscalQuarterEnding":"2024/03","expectedEps":-1.09,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-1.15},{"market":"US","date":"2024-03-29","symbol":"ELTX","fiscalQuarterEnding":"2023/12","expectedEps":-0.79,"name":null,"time":"盤前","type":"earning","dateTimestamp":1711684800000,"reportTimeType":"pre","actualEps":-3.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELTX","date":"2025-04-23","current":-1.550971,"percent":0.537736,"low":-9.235249,"twenty":-2.608104,"median":-1.656458,"eighty":-1.226414,"high":-0.963611,"avg":-1.96101,"sd":1.031567,"marketCap":80492298},"quantilePoints":[{"date":"2023-06-09","current":-9.235249,"twenty":-9.235249,"median":-9.19865,"eighty":-8.861936,"marketCap":260505032},{"date":"2023-06-16","current":-4.797096,"twenty":-9.19133,"median":-5.471097,"eighty":-5.286091,"marketCap":135315000},{"date":"2023-06-23","current":-3.669177,"twenty":-9.011993,"median":-5.35246,"eighty":-4.343178,"marketCap":103499000},{"date":"2023-06-30","current":-3.232452,"twenty":-8.711878,"median":-5.281964,"eighty":-3.931212,"marketCap":91180000},{"date":"2023-07-07","current":-3.782657,"twenty":-7.82363,"median":-4.797096,"eighty":-3.594899,"marketCap":106700000},{"date":"2023-07-14","current":-3.799851,"twenty":-5.457342,"median":-4.009616,"eighty":-3.669177,"marketCap":107185000},{"date":"2023-07-21","current":-3.868626,"twenty":-5.416077,"median":-3.868626,"eighty":-3.616907,"marketCap":109125000},{"date":"2023-07-28","current":-3.026831,"twenty":-5.342487,"median":-3.782657,"eighty":-3.314983,"marketCap":85379914},{"date":"2023-08-04","current":-2.958445,"twenty":-5.286091,"median":-3.758585,"eighty":-2.99472,"marketCap":83450898},{"date":"2023-08-11","current":-2.973312,"twenty":-5.075638,"median":-3.643386,"eighty":-2.969744,"marketCap":83870250},{"date":"2023-08-18","current":-2.842099,"twenty":-4.570137,"median":-3.57633,"eighty":-2.953093,"marketCap":83656289},{"date":"2023-08-25","current":-2.726636,"twenty":-4.18018,"median":-3.222136,"eighty":-2.868421,"marketCap":79553028},{"date":"2023-09-01","current":-2.370739,"twenty":-4.067388,"median":-3.000071,"eighty":-2.849368,"marketCap":69169264},{"date":"2023-09-07","current":-2.433882,"twenty":-3.951844,"median":-2.973312,"eighty":-2.844375,"marketCap":71011545},{"date":"2023-09-15","current":-2.413791,"twenty":-3.886508,"median":-2.973312,"eighty":-2.761879,"marketCap":70425365},{"date":"2023-09-22","current":-2.293245,"twenty":-3.841116,"median":-2.967365,"eighty":-2.647421,"marketCap":66908283},{"date":"2023-09-29","current":-2.413791,"twenty":-3.792973,"median":-2.953985,"eighty":-2.537207,"marketCap":70425365},{"date":"2023-10-04","current":-2.276024,"twenty":-3.782657,"median":-2.940605,"eighty":-2.474064,"marketCap":66405843},{"date":"2023-10-10","current":-2.098075,"twenty":-3.781281,"median":-2.875192,"eighty":-2.428715,"marketCap":61213961},{"date":"2023-10-19","current":-2.009101,"twenty":-3.779218,"median":-2.868708,"eighty":-2.413791,"marketCap":58618021},{"date":"2023-10-27","current":-1.922996,"twenty":-3.775091,"median":-2.867273,"eighty":-2.413791,"marketCap":56105820},{"date":"2023-11-03","current":-1.871334,"twenty":-3.740703,"median":-2.849368,"eighty":-2.290949,"marketCap":54598499},{"date":"2023-11-10","current":-1.690515,"twenty":-3.669177,"median":-2.844944,"eighty":-2.243878,"marketCap":49322877},{"date":"2023-11-17","current":-1.533738,"twenty":-3.658861,"median":-2.768921,"eighty":-2.084298,"marketCap":50453368},{"date":"2023-11-24","current":-1.527374,"twenty":-3.617595,"median":-2.739552,"eighty":-1.974659,"marketCap":50244018},{"date":"2023-12-01","current":-1.565558,"twenty":-3.614157,"median":-2.617571,"eighty":-1.90147,"marketCap":51500118},{"date":"2023-12-08","current":-1.48919,"twenty":-3.583895,"median":-2.583129,"eighty":-1.87076,"marketCap":48987917},{"date":"2023-12-15","current":-1.540102,"twenty":-3.452534,"median":-2.531467,"eighty":-1.708711,"marketCap":50662718},{"date":"2023-12-22","current":-1.476462,"twenty":-3.314983,"median":-2.474064,"eighty":-1.60527,"marketCap":48569217},{"date":"2023-12-29","current":-2.102685,"twenty":-3.232452,"median":-2.429577,"eighty":-1.641927,"marketCap":69169264},{"date":"2024-01-05","current":-2.03949,"twenty":-3.220072,"median":-2.413791,"eighty":-1.611379,"marketCap":67090423},{"date":"2024-01-12","current":-1.576818,"twenty":-3.100826,"median":-2.392265,"eighty":-1.585578,"marketCap":51870515},{"date":"2024-01-19","current":-1.427896,"twenty":-3.005423,"median":-2.30616,"eighty":-1.564031,"marketCap":46971633},{"date":"2024-01-26","current":-1.124213,"twenty":-2.973312,"median":-2.283466,"eighty":-1.540772,"marketCap":36981756},{"date":"2024-02-02","current":-1.314015,"twenty":-2.973312,"median":-2.260238,"eighty":-1.528392,"marketCap":43225429},{"date":"2024-02-09","current":-1.226414,"twenty":-2.973312,"median":-2.227231,"eighty":-1.508027,"marketCap":40343734},{"date":"2024-02-16","current":-1.220574,"twenty":-2.970933,"median":-2.10038,"eighty":-1.496317,"marketCap":40151621},{"date":"2024-02-23","current":-1.170933,"twenty":-2.967365,"median":-2.077039,"eighty":-1.484607,"marketCap":38518660},{"date":"2024-03-01","current":-1.185534,"twenty":-2.965581,"median":-2.037802,"eighty":-1.427936,"marketCap":38998943},{"date":"2024-03-08","current":-1.305255,"twenty":-2.958445,"median":-1.951697,"eighty":-1.350807,"marketCap":42937259},{"date":"2024-03-15","current":-1.530098,"twenty":-2.956661,"median":-1.917256,"eighty":-1.360152,"marketCap":50333611},{"date":"2024-03-22","current":-1.927222,"twenty":-2.947741,"median":-1.909363,"eighty":-1.380707,"marketCap":63397296},{"date":"2024-03-28","current":-2.178345,"twenty":-2.940605,"median":-1.925109,"eighty":-1.425549,"marketCap":71658156},{"date":"2024-04-05","current":-2.18389,"twenty":-2.875192,"median":-1.928736,"eighty":-1.427896,"marketCap":76862025},{"date":"2024-04-12","current":-2.872164,"twenty":-2.872164,"median":-2.000282,"eighty":-1.428095,"marketCap":101085828},{"date":"2024-04-19","current":-2.390082,"twenty":-2.870144,"median":-2.037802,"eighty":-1.436656,"marketCap":84118945},{"date":"2024-04-26","current":-2.64274,"twenty":-2.867273,"median":-2.070475,"eighty":-1.460017,"marketCap":93011227},{"date":"2024-05-03","current":-2.613699,"twenty":-2.860548,"median":-2.080854,"eighty":-1.476462,"marketCap":91989126},{"date":"2024-05-10","current":-2.758904,"twenty":-2.852923,"median":-2.121507,"eighty":-1.483377,"marketCap":97099633},{"date":"2024-05-17","current":-2.458726,"twenty":-2.860548,"median":-2.154849,"eighty":-1.484098,"marketCap":95873111},{"date":"2024-05-24","current":-2.3198,"twenty":-2.852923,"median":-2.20556,"eighty":-1.486644,"marketCap":90455973},{"date":"2024-05-31","current":-1.968554,"twenty":-2.850079,"median":-2.181118,"eighty":-1.488681,"marketCap":76759815},{"date":"2024-06-07","current":-2.125179,"twenty":-2.849368,"median":-2.152608,"eighty":-1.489212,"marketCap":82867106},{"date":"2024-06-14","current":-2.233016,"twenty":-2.846714,"median":-2.152608,"eighty":-1.492255,"marketCap":87071996},{"date":"2024-06-21","current":-1.741174,"twenty":-2.844944,"median":-2.140329,"eighty":-1.496317,"marketCap":67893594},{"date":"2024-06-28","current":-1.812189,"twenty":-2.844944,"median":-2.140329,"eighty":-1.498354,"marketCap":70662668},{"date":"2024-07-05","current":-0.967903,"twenty":-2.843237,"median":-2.110101,"eighty":-1.488172,"marketCap":37741454},{"date":"2024-07-12","current":-1.249432,"twenty":-2.834001,"median":-2.100781,"eighty":-1.469884,"marketCap":48719089},{"date":"2024-07-15","current":-1.260464,"twenty":-2.831302,"median":-2.098877,"eighty":-1.455345,"marketCap":49149280},{"date":"2024-08-02","current":-1.401267,"twenty":-2.828603,"median":-2.098877,"eighty":-1.436656,"marketCap":54639616},{"date":"2024-08-09","current":-1.290931,"twenty":-2.802466,"median":-2.080854,"eighty":-1.401267,"marketCap":50337284},{"date":"2024-08-16","current":-1.201045,"twenty":-2.796658,"median":-2.072003,"eighty":-1.349055,"marketCap":46438413},{"date":"2024-08-23","current":-1.241178,"twenty":-2.769689,"median":-2.062918,"eighty":-1.296495,"marketCap":47990130},{"date":"2024-08-30","current":-1.113164,"twenty":-2.768153,"median":-2.038646,"eighty":-1.281895,"marketCap":43040476},{"date":"2024-09-06","current":-1.110381,"twenty":-2.760754,"median":-2.011962,"eighty":-1.261256,"marketCap":42932874},{"date":"2024-09-13","current":-1.132616,"twenty":-2.753755,"median":-1.991463,"eighty":-1.24953,"marketCap":43792608},{"date":"2024-09-20","current":-1.430415,"twenty":-2.736707,"median":-1.971607,"eighty":-1.23844,"marketCap":55307011},{"date":"2024-09-27","current":-1.355277,"twenty":-2.727862,"median":-1.927222,"eighty":-1.247781,"marketCap":52401779},{"date":"2024-10-04","current":-1.35806,"twenty":-2.717602,"median":-1.920126,"eighty":-1.24953,"marketCap":52509380},{"date":"2024-10-11","current":-1.333014,"twenty":-2.703726,"median":-1.89225,"eighty":-1.251663,"marketCap":51540970},{"date":"2024-10-18","current":-1.327448,"twenty":-2.69392,"median":-1.871334,"eighty":-1.251663,"marketCap":51325767},{"date":"2024-10-25","current":-1.330231,"twenty":-2.68748,"median":-1.868821,"eighty":-1.256738,"marketCap":51433368},{"date":"2024-10-31","current":-1.15769,"twenty":-2.682816,"median":-1.860061,"eighty":-1.249543,"marketCap":44762095},{"date":"2024-11-08","current":-1.282921,"twenty":-2.678751,"median":-1.809791,"eighty":-1.251136,"marketCap":49604148},{"date":"2024-11-15","current":-1.251898,"twenty":-2.674104,"median":-1.720841,"eighty":-1.252073,"marketCap":58642648},{"date":"2024-11-22","current":-1.176095,"twenty":-2.654356,"median":-1.667384,"eighty":-1.249488,"marketCap":55091809},{"date":"2024-11-29","current":-1.171024,"twenty":-2.64274,"median":-1.629813,"eighty":-1.227353,"marketCap":54854273},{"date":"2024-12-06","current":-1.106606,"twenty":-2.639384,"median":-1.600178,"eighty":-1.22448,"marketCap":51836749},{"date":"2024-12-13","current":-1.148018,"twenty":-2.631897,"median":-1.571188,"eighty":-1.222594,"marketCap":53776586},{"date":"2024-12-20","current":-1.167573,"twenty":-2.62396,"median":-1.563013,"eighty":-1.217317,"marketCap":54692620},{"date":"2024-12-27","current":-1.166423,"twenty":-2.616797,"median":-1.547739,"eighty":-1.213926,"marketCap":54638735},{"date":"2025-01-03","current":-1.182527,"twenty":-2.613699,"median":-1.540102,"eighty":-1.211814,"marketCap":55393116},{"date":"2025-01-10","current":-1.304461,"twenty":-2.611376,"median":-1.530098,"eighty":-1.211814,"marketCap":61104858},{"date":"2025-01-17","current":-1.48161,"twenty":-2.609328,"median":-1.528647,"eighty":-1.213041,"marketCap":69403049},{"date":"2025-01-24","current":-1.656458,"twenty":-2.608318,"median":-1.528647,"eighty":-1.213574,"marketCap":77593471},{"date":"2025-01-31","current":-2.167199,"twenty":-2.60789,"median":-1.530098,"eighty":-1.21433,"marketCap":101518124},{"date":"2025-02-07","current":-2.162598,"twenty":-2.593884,"median":-1.54094,"eighty":-1.214734,"marketCap":101302587},{"date":"2025-02-14","current":-1.769189,"twenty":-2.583696,"median":-1.557921,"eighty":-1.214981,"marketCap":82874137},{"date":"2025-02-21","current":-1.863515,"twenty":-2.577932,"median":-1.565558,"eighty":-1.217317,"marketCap":87292655},{"date":"2025-02-28","current":-1.902626,"twenty":-2.570137,"median":-1.584118,"eighty":-1.220574,"marketCap":89124723},{"date":"2025-03-07","current":-1.833607,"twenty":-2.564329,"median":-1.603098,"eighty":-1.220574,"marketCap":85891661},{"date":"2025-03-14","current":-2.672649,"twenty":-2.570137,"median":-1.649192,"eighty":-1.221023,"marketCap":125194918},{"date":"2025-03-21","current":-2.747078,"twenty":-2.60789,"median":-1.669929,"eighty":-1.222594,"marketCap":128681358},{"date":"2025-03-28","current":-2.594838,"twenty":-2.612537,"median":-1.719708,"eighty":-1.224155,"marketCap":121550002},{"date":"2025-04-04","current":-1.679468,"twenty":-2.612537,"median":-1.718575,"eighty":-1.22448,"marketCap":87161019},{"date":"2025-04-11","current":-1.557114,"twenty":-2.610061,"median":-1.684991,"eighty":-1.225254,"marketCap":80811079},{"date":"2025-04-17","current":-1.492618,"twenty":-2.608747,"median":-1.667384,"eighty":-1.226414,"marketCap":77463875},{"date":"2025-04-23","current":-1.550971,"twenty":-2.608104,"median":-1.656458,"eighty":-1.226414,"marketCap":80492298}],"updateTime":1745554289763}}}